NSIS-B:CPH
Novozymes
449,00 DKK
arrow_upward
+1,47%(+6,50) 1 D
14. okt., 17:00:00 GMT+2 · DKK
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for NSIS-B …
Åpne
444,30 DKK
Høy
449,00 DKK
Lav
442,50 DKK
Markedsverdi
183,47 mrd.
Snittvolum
567,49k
Volum
853,52k
52 u høy
465,00 DKK
52 u lav
336,80 DKK
Utestående aksjer
414,56 mill.
Antall ansatte
11k
Åpne
444,30 DKK
Høy
449,00 DKK
Lav
442,50 DKK
Markedsverdi
183,47 mrd.
Snittvolum
567,49k
Volum
853,52k
52 u høy
465,00 DKK
52 u lav
336,80 DKK
Utestående aksjer
414,56 mill.
Antall ansatte
11k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Invezz
·
for 2 døgn siden
Topp 3 katalysatorer for S&P 500-indeksen denne uken: obligasjoner, kvartalstall, KPI
Invezz
·
for 1 døgn siden
Dow stiger 198 poeng mens USAs aksjer ender blandet før kvartalstall
Vietnam.vn
·
for 1 døgn siden
Amerikanske aksjer: Nasdaq Composite-indeksen faller før resultatrapporteringssesongen.
Profil
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
Om Novozymes
Administrerende direktørEster Baiget
Ansatte11,1k
Grunnlagt2000
Hovedkontor-
SektorSpeciality chemicals
Nettstednovonesis.com